Accès gratuit
Numéro
Med Sci (Paris)
Volume 20, Numéro 4, Avril 2004
Page(s) 431 - 436
Section M/S revues
DOI https://doi.org/10.1051/medsci/2004204431
Publié en ligne 15 avril 2004
  1. Launoy G, Grosclaude P, Pienkowski P, et al. Cancers digestifs en France. Comparaison de l’incidence dans 7 départements et estimation de l’incidence pour la France entière. Gastroenterol Clin Biol 1992; 16 : 633–8.
  2. Osler W, Mc Crae T. Cancer of the stomach. Philadelphia : Blakiston’s son and Co, 1900 : 157 p.
  3. Parsonnet J. When heredity is infectious. Gastroenterology 2000; 118 : 222–7.
  4. Malaty HM, El-Kasabany A, Graham D, et al. Age at acquisition of Helicobacter pylori infection : a follow-up study from infancy to adulthood. Lancet 2002; 359 : 931–5.
  5. Gasbarrini G, Pretolani S, Bonvicini F, et al. A population-based study of Helicobacter pylori infection in a european country : the San Marino study. Relation with gastrointestinal diseases. Gut 1995; 36 : 838–44.
  6. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2 : 28–37.
  7. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric cancer. N Engl J Med 1991; 325 : 1127–31.
  8. Helicobacter and cancer cooperative group. Gastric cancer and Helicobacter pylori : a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49 : 347–53.
  9. International agency for research of cancer (IARC). Infection with Helicobacter pylori. Monographs on the evaluation of carcinogenic risks to humans, vol. 61. Lyon : IARC, 1994 : 177–240.
  10. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and development of gastric cancer. N Engl J Med 2001; 345 : 784–9.
  11. Correa P. Human gastric carcinogenesis : a multistep and multifactorial process. First american cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52 : 6735–40.
  12. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40 : 297–301.
  13. Labenz J, Malfertheiner P. Helicobacter pylori in gastro-oesophageal reflux disease : causal agent, independent or protective factor ? Gut 1997; 41 : 277–80.
  14. Van der Hulst RWM, Van der Ende A, Dekker FW, et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA : a prospective one-year follow-up study. Gastroenterology 1997; 40 : 297–301.
  15. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens : antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996; 91 : 1785–8.
  16. Israel DA, Salama N, Arnold CN, et al. Helocobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001; 107 : 611–20.
  17. Chiou GC, Chan CC, Sheu DL, et al. Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut 2001; 48 : 598–604.
  18. Galmiche A, Rassow J, Doye A, et al. The N-terminal 34 kDa fragments of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrom C release. EMBO J 2000; 68 : 6361–70.
  19. Suganuma M, Kurusu M, Okabe S, et al. Helicobacter pylori membrane protein 1 : a new carcinogenic factor of Helicobacter pylori. Cancer Res 2001; 61 : 6356–9.
  20. Hansson LE, Nyrén O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335 : 242–9.
  21. Peek RM, Wirth HP, Moss SF, et al. Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 2000; 118 : 48–59.
  22. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118 : 36–47.
  23. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer : overview and guidelines for management. J Med Genet 1999; 36 : 873–80.
  24. Brenner H, Bode G, Boeing H. Helicobacter pylori among offspring of patients with stomach cancer. Gastroenterology 2000; 118 : 31–5.
  25. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients : critical role of H. pylori. Gastroenterology 2000; 118 : 22–30.
  26. El-Omar EM, Carrington M, Chow WH. IL1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404 : 398–402.
  27. El-Omar EM. The importance of interleukin 1béta in Helicobacter pylori associated disease. Gut 2001; 48 : 743–47.
  28. Machado JC, Pharoah P, Sousa S, et al. Interleukin-1béta and interleukin-1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121 : 823–29.
  29. Hwang I, Kodama T, Kikuchi S, et al. Effect of interleukin-1 polymorphisms on gastric acid mucosal interleukin-1béta production in Helicobacter pylori infection. Gastroenterology 2002; 123 : 1793–803.
  30. Fox JG, Beck P, Dangler CA, et al. Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces Helicobacter-induced gastric atrophy. Nat Med 2000; 6 : 536–42.
  31. Park WS, Oh RR, Park JY, et al. Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 2000; 119 : 691–8.
  32. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers 1997; 6 : 639–42.
  33. Parsonnet J, Harris RA, Hack HM, Owens DK. Modeling cost effectiveness of Helicobacter pylori sreening to prevent gastric cancer : a mandate for clinical trials. Lancet 1996; 348 : 150–4.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.